Organization profile

A cohort within the PMBRC, the Ocular Therapeutics Research Group (OTRG) is focused primarily on the development and production of novel therapeutics to treat various chronic and acute diseases of the eye. This is achieved by developing new nano- and micro-formulations, investigating novel therapeutics and designing innovative drug delivery platforms to improve patient outcomes and quality of life issues for a range of ophthalmic conditions. Using similarly developed formulations, these technologies are also applied to other pressing societal challenges that include Covid-19 and antimicrobial resistance.

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 7 - Affordable and Clean Energy
  • SDG 14 - Life Below Water

Fingerprint

Dive into the research topics where Ocular Therapeutics Research Group is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or